SCHEMBL9056402

SCHEMBL9056402

O=P(O)(CCCOCc1ccccc1)COc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.58
CYP2C9 P11712 1/20 0.58
TSHR P16473 3/20 0.44
CETP P11597 3/20 0.40
ALPG P10696 1/20 0.40
PTK2B Q14289 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
POLB P06746 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
PTGS1 P23219 1/20 0.39
SLC6A2 P23975 1/20 0.39
PTGS2 P35354 1/20 0.39
SLC6A3 Q01959 1/20 0.39
HIF1A Q16665 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
NR4A1 P22736 1/20 0.39
NR4A2 P43354 1/20 0.39
NR4A3 Q92570 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8732784 0.88 POLB (0.47) CYP2C19CYP2C9TSHRTDP1L3MBTL1
SCHEMBL8729694 0.85 MAOB (0.42) CYP2C19CYP2C9TDP1L3MBTL1SLC6A2
SCHEMBL8729697 0.85 MAOB (0.42) CYP2C19CYP2C9TDP1L3MBTL1SLC6A2
SCHEMBL8729688 0.85 MAOB (0.42) CYP2C19CYP2C9TDP1L3MBTL1SLC6A2
SCHEMBL8727266 0.82 TSHR (0.49) TSHRCETPALPGPTK2BPOLB
SCHEMBL8733377 0.80 TSHR (0.52) TSHRCETPALPGPTK2BTDP1
SCHEMBL8727138 0.78 NPC1 (0.44) L3MBTL1
SCHEMBL8758717 0.77 CYP2C9 (0.54) CYP2C19CYP2C9TSHRPOLB
SCHEMBL9056789 0.75 CYP2C9 (0.64) CYP2C19CYP2C9CETPSLC6A2SLC6A3
SCHEMBL4068237 0.74 CETP (0.53) TSHRCETPTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996004234-A1 ARYLOXY ANDARYCTHIO PROPANOLAMINE DERIVATIVES USEFUL AS B3-ADRENORECEPTOR AGONISTS AND ANTAGONS OF THE B1 AND B2 ADRENORECEPTORS AND PHARMACEUTICAL COMPOSITION THEREOF SMITHKLINE BEECHAM PLC (GB) 1996-02-15 WO disclosed